Telomere Length Maintenance in Cancer: At the Crossroad between Telomerase and Alternative Lengthening of Telomeres (ALT)

International Journal of Molecular Sciences
Marco De VitisAntonella Sgura

Abstract

Eukaryotic cells undergo continuous telomere shortening as a consequence of multiple rounds of replications. During tumorigenesis, cells have to acquire telomere DNA maintenance mechanisms (TMMs) in order to counteract telomere shortening, to preserve telomeres from DNA damage repair systems and to avoid telomere-mediated senescence and/or apoptosis. For this reason, telomere maintenance is an essential step in cancer progression. Most human tumors maintain their telomeres expressing telomerase, whereas a lower but significant proportion activates the alternative lengthening of telomeres (ALT) pathway. However, evidence about the coexistence of ALT and telomerase has been found both in vivo in the same cancer populations and in vitro in engineered cellular models, making the distinction between telomerase- and ALT-positive tumors elusive. Indeed, after the development of drugs able to target telomerase, the capability for some cancer cells to escape death, switching from telomerase to ALT, was highlighted. Unfortunately, to date, the mechanism underlying the possible switching or the coexistence of telomerase and ALT within the same cell or populations is not completely understood and different factors could be involved. In rec...Continue Reading

References

May 31, 1990·Nature·C B HarleyC W Greider
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·R K MoyzisJ R Wu
Aug 21, 1996·Journal of the National Cancer Institute·J GuptaS Bacchetti
Oct 10, 1996·Experimental Cell Research·A G BodnarC P Chiu
Nov 14, 1997·Molecular Human Reproduction·G A Ulaner, L C Giudice
Feb 25, 1998·Molecular Carcinogenesis·M KatohM Oshimura
Sep 14, 2001·Human Molecular Genetics·M A CeroneS Bacchetti
Nov 13, 2001·Oncogene·K JensenP S Freemont
Feb 19, 2002·Oncogene·Jeremy D HensonRoger R Reddel
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Pu YanLouis Guillou
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Sheila A StewartRobert A Weinberg
Apr 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·David J KurzJorge D Erusalimsky
May 24, 2003·Leukemia·S ZimmermannU M Martens
Nov 11, 2003·Nature·Fabrizio d'Adda di FagagnaStephen P Jackson
Apr 3, 2004·Cancer Research·J Arturo Londoño-VallejoRoger R Reddel
Apr 28, 2004·The American Journal of Pathology·Elizabeth MontgomeryAlan K Meeker
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert P SandersJeffrey S Dome
Oct 29, 2004·Molecular and Cellular Biology·Anthony J Cesare, Jack D Griffith
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jay E JohnsonDominique Broccoli
Sep 17, 2005·Genes & Development·Titia de Lange
Mar 28, 2006·Nature Cell Biology·Susana GonzaloMaría A Blasco
Jun 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Y Y DanN Fausto
Mar 14, 2007·British Journal of Cancer·E Hiyama, K Hiyama
Sep 12, 2007·The Journal of Cell Biology·Roberta BenettiMaría A Blasco
Oct 12, 2007·Nature Reviews. Molecular Cell Biology·Rosa Bernardi, Pier Paolo Pandolfi
Jan 15, 2008·Development·Yongqing LiuDouglas C Dean
Jan 17, 2008·The Journal of Clinical Endocrinology and Metabolism·Tobias ElseGary D Hammer
Mar 4, 2008·International Journal of Cancer. Journal International Du Cancer·Jennie N JeyapalanNicola J Royle
Jun 21, 2008·Clinical & Experimental Metastasis·Erik W Thompson, Elizabeth D Williams

❮ Previous
Next ❯

Citations

Apr 11, 2018·Journal of Experimental & Clinical Cancer Research : CR·Guihong LiHaiyan Huang
Feb 13, 2019·International Journal of Molecular Sciences·Sergey S ShishkinKsenia Lisitskaya
Mar 16, 2019·Carcinogenesis·Nalini SrinivasRajiv Kumar
Jan 19, 2019·Journal of Experimental & Clinical Cancer Research : CR·Stefano CacchioneAngela Rizzo
Nov 24, 2019·International Journal of Molecular Sciences·Sandra Ackermann, Matthias Fischer
Feb 13, 2020·Reproductive Sciences·Brunna Nepomuceno ColattoJossimara Polettini
Jan 10, 2020·Current Topics in Medicinal Chemistry·Joseph BereiNeelu Puri
Apr 23, 2020·International Journal of Molecular Sciences·Kristine SalminaJekaterina Erenpreisa
Jul 10, 2019·International Journal of Molecular Sciences·Xiaotian Yuan, Dawei Xu
Jun 16, 2019·International Journal of Molecular Sciences·Benedetta Donati, Alessia Ciarrocchi
Apr 8, 2020·Cell & Bioscience·Jun Tan, Li Lan
Jul 28, 2020·Genes·Isaac Armendáriz-CastilloCésar Paz-Y-Miño
Nov 19, 2018·Molecular Biology Reports·Aleksandra RomaniukBłażej Rubiś
Mar 19, 2020·Cancer Management and Research·Mariana MoraisRui Medeiros
Jul 4, 2020·Journal of Gastrointestinal Cancer·Sogand VahidiAli Akbar Samadani
May 19, 2019·Andrology·J Feichtinger, R J McFarlane
Jan 14, 2020·Thyroid : Official Journal of the American Thyroid Association·Huiling HeAlbert de la Chapelle
Sep 10, 2020·Frontiers in Oncology·Chen LuoZhengming Zhu
Oct 29, 2020·Technology in Cancer Research & Treatment·Yuqi SunXueren Gao
Dec 4, 2020·Genes·Aurora Irene IdilliMaria Caterina Mione
Apr 12, 2020·Molecular Cancer Research : MCR·Josh Lewis SternFranklin W Huang
Aug 11, 2020·Computational and Structural Biotechnology Journal·Tomas AramburuEmmanuel Skordalakes
Oct 31, 2020·Frontiers in Physiology·Jossimara Polettini, Marcia Guimarães da Silva
Jun 3, 2021·Children·Margherita LeroneKatia Mazzocco
Jun 3, 2021·Cancers·Martina ValenzuelaFrancesco Berardinelli
Jul 3, 2021·International Journal of Molecular Sciences·Barbara JacczakEwa Totoń
Jun 17, 2021·Clinics·Gabriel Arantes Dos SantosMiguel Srougi
Jul 16, 2021·Journal of Autoimmunity·Anne-Charlotte HebaNdeye Coumba Ndiaye
Aug 28, 2021·Biomolecules·Jesmin Akter, Takehiko Kamijo
Aug 28, 2021·International Journal of Molecular Sciences·Sidrit UruciNitika Taneja
Sep 8, 2021·Breast Cancer Research : BCR·Lu YangPeijun Liu

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM847

Methods Mentioned

BETA
transfection

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.